Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results

Go back to Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.31 --0 (-0%)
Previous Close $0.31    52 Week High $ 
Open $0.31    52 Week Low $ 
Day High $0.32    P/E N/A 
Day Low $0.30    EPS $ 
Volume 332,647